MétaCan
Menu
← Back to cohort

Correction: Trends in Asthma-Related Direct Medical Costs from 2002 to 2007 in British Columbia, Canada: A Population Based-Cohort Study

2013· article· en· W4231531615 on OpenAlexafffundabout
Pierrick Bedouch, Mohsen Sadatsafavi, Carlo A. Marra, J. Mark FitzGerald, Larry D. Lynd

Bibliographic record

VenuePLoS ONE · 2013
Typearticle
Languageen
FieldMedicine
TopicAsthma and respiratory diseases
Canadian institutionsVancouver Coastal HealthCentre for Advancing Health OutcomesUniversity of British Columbia
FundersUniversity of British ColumbiaCanadian Institutes of Health ResearchAllerGenSanofiMichael Smith Health Research BCGlaxoSmithKlineGenentechAstraZenecaPfizer
KeywordsAsthmaCohort studyCohortMedicineDemographyMEDLINEGeographyPopulationEnvironmental healthBiologyInternal medicineSociology

Abstract

fetched live from OpenAlex

Background: Asthma-related health resource use and costs may be influenced by increasing asthma prevalence, changes to asthma management guidelines, and new medications over the last decade.The objective of this work was to analyze direct asthma-related medical costs, and trends in total and per-patient costs of hospitalizations, physician visits, and medications.Methods: A cohort of asthma patients from British Columbia (BC), Canada, was created.Asthma patients were identified using a validated case definition.Costs for hospitalizations, physician visits, and medications were calculated from billing records (in 2008 Canadian dollars).Trends in total and per-patient costs over the study period were analyzed using Generalized Linear Models.Results: 398,235 patients satisfied the asthma case definition (mid-point prevalence 8.0%).Patients consumed $315.9 million (M) in direct asthma-related health resources between 2002 and 2007.Hospitalizations, physician visits, and medication costs accounted for 16.0%, 15.7% and 68.2% of total costs, respectively.Cost of asthma increased from $49.4 M in 2002 to $54.7 M in 2007.Total annual costs attributable to hospitalizations and physician visits decreased (239.8% and 225.5%, respectively; p,0.001), while medication costs increased (+38.7%;p,0.001).Interpretation: This population-based analysis shows that the total direct cost of asthma in BC has increased since 2002, mainly due to a rise in asthma prevalence and cost of medication.Combination therapy with inhaled corticosteroids/longacting beta-agonists has become a significant component of the cost of asthma.Although billing records capture only a fraction of the true burden of asthma, the simultaneous increase in medication costs and reductions in hospitalization and physician visit costs provides valuable insight for policy makers into the shifts in asthma-related resource use.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.006
metaresearch head score (Gemma)0.100
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.141
Threshold uncertainty score0.283

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0060.100
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0020.002
Bibliometrics0.0040.010
Science and technology studies0.0020.001
Scholarly communication0.0030.002
Open science0.0050.002
Research integrity0.0020.004
Insufficient payload (model declined to judge)0.0790.013

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.010
GPT teacher head0.222
Teacher spread0.212 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2013
Admission routes3
Has abstractyes

Explore more

Same venuePLoS ONE→Same topicAsthma and respiratory diseases→French-language works237,207→